THE VALUE OF ANTI-VEGF DRUGS IN THE TREATMENT OF DIABETIC RETINOPATHY (LITERATURE REVIEW)

NORMATOVA Nargiza Mirshovkatovna, KHAMIDULLAEV Firdavs Faridovich, SAIDOV Temur Tolibovich

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali · 2023-yil

Annotatsiya

The article discusses the treatment with the use of angiogenesis inhibitors in the complex treatment of diabetic macular edema. A comparative analysis of all types of anti-VGEF drugs for macular edema is given. The use of brolucizumab is described in detail as the most optimal method among anti-VGEF drugs for the elimination of macular edema. It also provides the latest data with clinically validated data on the use of this drug.

Maqola ma’lumotlari
MualliflarNORMATOVA Nargiza Mirshovkatovna, KHAMIDULLAEV Firdavs Faridovich, SAIDOV Temur Tolibovich
JurnalJournal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali
Nashr sanasi2023-02-07
Jild7
Son6
TilO‘zbek

Kalit so‘zlar

ингибиторы ангиогенеза, VGEF, сахарный диабет, диабетическая ретинопатия,макулярный отек, angiogenesis inhibitors, VGEF, diabetes mellitus, diabetic retinopathy, macular edema, angiogenez ingibitorlari, VGEF, qandli diabet, diabetik retinopatiya ,makulyar shish

Ilmiy soha

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali jurnalidan boshqa maqolalar

Journal of Biomedicine and Practice – Biomeditsina va amaliyot jurnali — barcha maqolalar